HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Waardenburg Syndrome (Klein Syndrome)

Rare, autosomal dominant disease with variable penetrance and several known clinical types. Characteristics may include depigmentation of the hair and skin, congenital deafness, heterochromia iridis, medial eyebrow hyperplasia, hypertrophy of the nasal root, and especially dystopia canthorum. The underlying cause may be defective development of the neural crest (neurocristopathy). Waardenburg's syndrome may be closely related to piebaldism. Klein-Waardenburg Syndrome refers to a disorder that also includes upper limb abnormalities.
Also Known As:
Klein Syndrome; Klein's Syndrome; Waardenburg Syndrome Type 1; Waardenburg Syndrome Type 3; Waardenburg Syndrome with Dystopia Canthorum; Waardenburg Syndrome with Upper Limb Anomalies; Waardenburg Syndrome, Type 1; Waardenburg Syndrome, Type 3; Waardenburg Syndrome, Type III; Waardenburg's Syndrome Type 1; Waardenburg-Klein Syndrome; White Forelock (Poliosis) Syndrome with Multiple Congenital Malformations; Klein Waardenburg Syndrome; Kleins Syndrome; Syndrome, Klein; Syndrome, Klein's; Syndrome, Klein-Waardenburg; Syndrome, Waardenburg; Syndrome, Waardenburg's; Syndrome, Waardenburg-Klein; Waardenburg Klein Syndrome; Waardenburgs Syndrome; Klein-Waardenburg Syndrome; Waardenburg's Syndrome
Networked: 115 relevant articles (0 outcomes, 13 trials/studies)

Disease Context: Research Results

Related Diseases

1. Deafness (Deaf Mutism)
2. Hearing Loss (Hearing Impairment)
3. Sensorineural Hearing Loss
4. Hypopigmentation (Hypomelanosis)
5. Hirschsprung Disease (Hirschsprung's Disease)

Experts

1. Feng, Yong: 5 articles (01/2022 - 02/2015)
2. Zhang, Hua: 4 articles (05/2018 - 02/2015)
3. Guo, Weiwei: 3 articles (06/2021 - 01/2016)
4. Yang, Shiming: 3 articles (06/2021 - 01/2016)
5. Chen, Hongsheng: 3 articles (08/2017 - 02/2015)
6. Fisher, David E: 3 articles (01/2012 - 11/2003)
7. Corry, Gareth N: 3 articles (09/2010 - 12/2005)
8. Underhill, D Alan: 3 articles (09/2010 - 12/2005)
9. Pavan, William J: 3 articles (07/2008 - 02/2006)
10. Ma, Jing: 2 articles (05/2022 - 06/2016)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Waardenburg Syndrome:
1. Proteins (Proteins, Gene)FDA Link
2. Microphthalmia-Associated Transcription FactorIBA
3. DNA (Deoxyribonucleic Acid)IBA
4. placental alkaline phosphataseIBA
5. Endothelin Receptors (Endothelin Receptor)IBA
6. Nuclear Localization Signals (Nuclear Localization Signal)IBA
7. OligodeoxyribonucleotidesIBA
8. 12S ribosomal RNAIBA
9. Transcription Factors (Transcription Factor)IBA
10. Nonsense Codon (Nonsense Mutation)IBA

Therapies and Procedures

1. Cochlear Implantation
2. Cochlear Implants (Cochlear Implant)
3. Therapeutics
01/01/2022 - "Genetic insights, disease mechanisms, and biological therapeutics for Waardenburg syndrome."
01/01/2020 - ": 4H: Hypomyelination, hypogonadotropic hypogonadism and hypodontia; AAV: Adeno-associated virus; AD: autosomal dominant; AGS: Aicardi-Goutieres syndrome; ALSP: Axonal spheroids and pigmented glia; APGBD: Adult polyglucosan body disease; AR: autosomal recessive; ASO: Antisense oligonucleotide therapy; AxD: Alexander disease; BAEP: Brainstem auditory evoked potentials; CAA: Cerebral amyloid angiopathy; CADASIL: Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy; CARASAL: Cathepsin A-related arteriopathy with strokes and leukoencephalopathy; CARASIL: Cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy; CGH: Comparative genomic hybridization; ClC2: Chloride Ion Channel 2; CMTX: Charcot-Marie-Tooth disease, X-linked; CMV: Cytomegalovirus; CNS: central nervous system; CRISP/Cas9: Clustered regularly interspaced short palindromic repeat/CRISPR-associated 9; gRNA: Guide RNA; CTX: Cerebrotendinous xanthomatosis; DNA: Deoxyribonucleic acid; DSB: Double strand breaks; DTI: Diffusion tensor imaging; FLAIR: Fluid attenuated inversion recovery; GAN: Giant axonal neuropathy; H-ABC: Hypomyelination with atrophy of basal ganglia and cerebellum; HBSL: Hypomyelination with brainstem and spinal cord involvement and leg spasticity; HCC: Hypomyelination with congenital cataracts; HEMS: Hypomyelination of early myelinated structures; HMG CoA: Hydroxy methylglutaryl CoA; HSCT: Hematopoietic stem cell transplant; iPSC: Induced pluripotent stem cells; KSS: Kearns-Sayre syndrome; L-2-HGA: L-2-hydroxy glutaric aciduria; LBSL: Leukoencephalopathy with brainstem and spinal cord involvement and elevated lactate; LCC: Leukoencephalopathy with calcifications and cysts; LTBL: Leukoencephalopathy with thalamus and brainstem involvement and high lactate; MELAS: Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke; MERRF: Myoclonic epilepsy with ragged red fibers; MLC: Megalencephalic leukoencephalopathy with subcortical cysts; MLD: metachromatic leukodystrophy; MRI: magnetic resonance imaging; NCL: Neuronal ceroid lipofuscinosis; NGS: Next generation sequencing; ODDD: Oculodentodigital dysplasia; PCWH: Peripheral demyelinating neuropathy-central-dysmyelinating leukodystrophy-Waardenburg syndrome-Hirschprung disease; PMD: Pelizaeus-Merzbacher disease; PMDL: Pelizaeus-Merzbacher-like disease; RNA: Ribonucleic acid; TW: T-weighted; VWM: Vanishing white matter; WES: whole exome sequencing; WGS: whole genome sequencing; X-ALD: X-linked adrenoleukodystrophy; XLD: X-linked dominant; XLR: X-linked recessive."
4. Telescopes
5. Iridectomy